Stay updated with breaking news from Upcoming Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NX-5948 received Fast Track designation from the FDA NX-5948 showed positive results in Phase 1 clinical trial establishing a robust foundation for advancement in CLL Licensed to Gilead a new...
Strategic collaboration with Seagen and strong financial position highlight the quarter
Two books arrived at my doorstep in tandem at the top of September. The first I opened is from the Indiana Historical Society Press, “Homecomings: A Writer’s Memoir” by Norbert
Announced Phase 1b expansion cohorts for NX-2127 in non-Hodgkin’s lymphomas Presented data highlighting the potent cellular activity of both NX-5948 and NX-2127 against BTKi resistance mutations ...
/PRNewswire/ -- The "Space In-Orbit Refueling Market - A Global and Regional Analysis: Focus on Application, End User, Capability, and Country - Analysis and...